Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).

Medical Mycology
Amir ArastehfarFarid Zand

Abstract

Systematic candidemia studies, especially in southern Iran, are scarce. In the current prospective study, we investigated candidemia in three major healthcare centers of Shiraz, the largest city in southern Iran. Yeast isolates from blood and other sterile body fluids were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and subjected to antifungal susceptibility testing (AFST) using the broth microdilution method. Clinical data were retrieved from patients' medical records. In total, 113 yeast isolates were recovered from 109 patients, over 60% of whom received fluconazole. Antifungal drugs were prescribed without considering species identification or AFST. The all-cause mortality rate was 28%. Almost 30% of the patients were from intensive care units (ICUs). Candida albicans (56/113; 49.5%) was the most prevalent species followed by C. glabrata (26/113; 23%), C. parapsilosis (13/113; 11.5%), C. tropicalis (7/113; 6.2%), and C. dubliniensis (5/113; 4.4%). Only five isolates showed antifungal resistance or decreased susceptibility to fluconazole: one C. orthopsilosis isolate from an azole-naïve patient and two C. glabrata, one C. albicans, and one C. dubliniensis isolates from patients ...Continue Reading

References

Dec 21, 2012·Science Translational Medicine·Gordon D BrownTheodore C White
Apr 2, 2013·The Journal of Antimicrobial Chemotherapy·Fengmei GuoUNKNOWN China-SCAN Team
Oct 12, 2013·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Ing-Moi HiiChih-Yen Chang
Dec 17, 2014·Intensive Care Medicine·Arunaloke ChakrabartiDeepak Mendiratta
Jun 21, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L HesstvedtUNKNOWN Norwegian Yeast Study Group
Dec 19, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasJack D Sobel
Jan 9, 2016·Annals of Intensive Care·Olivier LeroyUNKNOWN AmarCAND2 study group
Jan 27, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasJack D Sobel
Sep 14, 2016·Biosensors & Bioelectronics·Wen-Bin LeeGwo-Bin Lee
Feb 17, 2017·The Journal of Antimicrobial Chemotherapy·Belinda ChapmanUNKNOWN Australian and New Zealand Mycoses Interest Group
Jan 6, 2018·The Journal of Antimicrobial Chemotherapy·Frederic LamothThierry Calandra
Mar 28, 2018·Antimicrobial Agents and Chemotherapy·Xin HouYing-Chun Xu
Jul 25, 2018·Antimicrobial Agents and Chemotherapy·Sarah G WhaleyP David Rogers
Sep 12, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kaitlin BenedictKarlyn D Beer
Nov 30, 2018·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Jae-Hoon KoKyong Ran Peck
Apr 14, 2019·Journal of Global Antimicrobial Resistance·Sevtap Arikan-AkdagliDuygu Fındık
Jul 10, 2019·Diagnostic Microbiology and Infectious Disease·Jae-Hoon KoKyong Ran Peck
Oct 2, 2019·Journal of Fungi·Amir ArastehfarTeun Boekhout

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.